The DimAb™ development platform is different from traditional hybridoma fusion technologies in that it can directly isolate IgG genes from B cells of immunized animals
Optibrium Launches Cerella, an artificial intelligence software platform for drug discovery that delivers active learning using advanced deep learning methods